$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How effective is baricitinib in treating vitiligo?
2026-02-01 22:25:32
Check Details
How effective is baricitinib in treating rheumatoid arthritis?
2026-02-01 22:25:32
Check Details
Can baricitinib tablets be stopped suddenly?
2026-02-01 22:25:32
Check Details
Key precautions to follow when taking temozolomide
2026-02-01 22:25:32
Check Details
How many cycles does it take to take temozolomide?
2026-02-01 22:25:32
Check Details
How long does it take to stop using temozolomide capsules?
2026-02-01 22:25:32
Check Details
How long does it take to see the effects of taking temozolomide?
2026-02-01 22:25:32
Check Details
To explore the therapeutic adaptability of temozolomide in patients with brainstem glioma
2026-02-01 22:25:32
Check Details
The current status of the marketing of Mobotinib (Mobosetinib) in China and its therapeutic applications
2026-02-01 22:25:32
Check Details
The latest price and buying guide of Mobotinib (Mobosetinib) in 2024
2026-02-01 22:25:32
Check Details
Analysis of the progress and market status of Mobotinib (Mobosetinib) included in medical insurance
2026-02-01 22:25:32
Check Details
Mobotinib: the leader in third-generation EGFR-targeted drugs
2026-02-01 22:25:32
Check Details
1
2
...
949
950
951
952
953
954
955
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
2
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
3
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
4
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
5
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
6
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
7
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
8
Elagolix Side Effects and Safety Guide
9
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations
10
Lytenava: The First FDA-Approved Ophthalmic Bevacizumab Formulation
11
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
12
Simtriyo (Centanafadine): World's First NDSRI ADHD Drug Approved by FDA